Sunday - December 22, 2024

Substituted Imidazo[l,2-A]pyrazines and Pyrazino[l,2-A] Pyrimidines as Topical Agents for Dermatological Applications

2024-12-17

ALEXANDRIA, Virginia, Dec. 17 -- GENESIS MOLECULAR TECHNOLOGIES, INC., Austin, Texas has been assigned a patent (No. US 12168665 B2, initially filed April 27, 2023) developed by Fuqiang Ruan, Bellevue, Washington, for "Substituted imidazo[l,2-a]pyrazines and pyrazino[l,2-a] pyrimidines as topical agents for dermatological applications." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Substituted Imidazo[l,2-A]pyrazines and Pyrazino[l,2-A] Pyrimidines as Topical Agents for Dermatological Applications

Information Request Form

Copyright Targeted News Service 2024